Multiple Sclerosis and Other CNS Inflammatory Diseases

June 2019, Volume 25, Issue 3
BROWSE ISSUES

Multiple Sclerosis and Other CNS Inflammatory Diseases

June 2019, Vol.25, No.3

Guest Editor:

Dean M. Wingerchuk, MD, MSC, FRCPC, FAAN

Editor-in-Chief:

STEVEN L. LEWIS, MD, FAAN

ISSN: 1080-2371

Online ISSN: 1538-6899

REVIEW ARTICLES
Multiple Sclerosis Risk Factors and Pathogenesis
Nourbakhsh, Bardia; Mowry, Ellen M.
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 596-610
doi: 10.1212/CON.0000000000000725
Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis
Solomon, Andrew J.
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 611-635
doi: 10.1212/CON.0000000000000728
Phases and Phenotypes of Multiple Sclerosis
Kantarci, Orhun H.
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 636-654
doi: 10.1212/CON.0000000000000737
Management of Multiple Sclerosis Relapses
Repovic, Pavle
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 655-669
doi: 10.1212/CON.0000000000000739
Clinically Isolated Syndrome and Early Relapsing Multiple Sclerosis
Metz, Luanne M.
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 670-688
doi: 10.1212/CON.0000000000000729
Highly Aggressive Multiple Sclerosis
Bowen, James D.
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 689-714
doi: 10.1212/CON.0000000000000731
Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies
Gross, Robert H.; Corboy, John R.
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 715-735
doi: 10.1212/CON.0000000000000738
Progressive Multiple Sclerosis
Ontaneda, Daniel
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 736-752
doi: 10.1212/CON.0000000000000727
Management of Multiple Sclerosis Symptoms and Comorbidities
Tobin, W. Oliver
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 753-772
doi: 10.1212/CON.0000000000000732
Pregnancy and Family Planning in Multiple Sclerosis
Langer-Gould, Annette M.
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 773-792
doi: 10.1212/CON.0000000000000745
Pediatric Central Nervous System Demyelinating Diseases
Chitnis, Tanuja
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 793-814
doi: 10.1212/CON.0000000000000730
Neuromyelitis Optica Spectrum Disorder and Other Non–Multiple Sclerosis Central Nervous System Inflammatory Diseases
Flanagan, Eoin P.
CONTINUUM: Lifelong Learning in Neurology
June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - p 815-844
doi: 10.1212/CON.0000000000000742
Editor's Preface
Articles
Key Points
Abbreviations
Appendix
Issue Overview

List of Abbreviations

CONTINUUM: Lifelong Learning in Neurology June 2019 - Volume 25 - Issue 3, Multiple Sclerosis and Other CNS Inflammatory Diseases - [no page #] doi: 10.1212/01.CON.0000558256.98247.a5

Multiple Sclerosis and Other CNS Inflammatory Diseases

AAN American Academy of Neurology

ACTH Adrenocorticotropic hormone

ADEM Acute disseminated encephalomyelitis

AQP4 Aquaporin-4

ATPase Adenosine triphosphatase

BUN Blood urea nitrogen

CI Confidence interval

CLIPPERS Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids

CMV Cytomegalovirus

CNS Central nervous system

CRMP-5 Collapsin response mediator protein-5

CSF Cerebrospinal fluid

DNA Deoxyribonucleic acid

EBNA1 Epstein-Barr nuclear antigen 1

EBV Epstein-Barr virus

ECG Electrocardiogram

EDSS Expanded Disability Status Scale

EEG Electroencephalography

ELISA Enzyme-linked immunosorbent assay

EMA European Medicines Agency

FDA US Food and Drug Administration

FLAIR Fluid-attenuated inversion recovery

GABA γ-Aminobutyric acid

GABA-ergic γ-Aminobutyric acid–mediated

GFAP Glial fibrillary acidic protein

HIV Human immunodeficiency virus

IgG Immunoglobulin G

IgM Immunoglobulin M

IM Intramuscular

IQ Intelligence quotient

IV Intravenous

IVIg Intravenous immunoglobulin

LETM Longitudinally extensive transverse myelitis

MMSE Mini-Mental State Examination

MOG Myelin oligodendrocyte glycoprotein

MRI Magnetic resonance imaging

MS Multiple sclerosis

MSFC Multiple Sclerosis Functional Composite

NEDA No evidence of disease activity

NMDAN-methyl-D-aspartate

NMO Neuromyelitis optica

NMOSD Neuromyelitis optica spectrum disorder

PCR Polymerase chain reaction

PHQ Patient Health Questionnaire

PML Progressive multifocal leukoencephalopathy

PRES Posterior reversible encephalopathy syndrome

REM Rapid eye movement

RLS Restless legs syndrome

SIADH Syndrome of inappropriate secretion of antidiuretic hormone

SNRI Serotonin norepinephrine reuptake inhibitor

SSRI Selective serotonin reuptake inhibitor

THC Tetrahydrocannabinol

TSH Thyroid-stimulating hormone

© 2019 American Academy of Neurology.